Shi-Ming Zhang, Qing-Ge Zhu, Xiao-Xiao Ding, Song Lin, Jing Zhao, Lei Guan, Ting Li, Bing He, Hu-Qin Zhang The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an JiaoTong University, Xi’an, 710049, China Background: The prognostic value of EGFR and KRAS mutations in resected non-small cell lung cancer (NSCLC) has been reported. However, conflicting results were reported in these studies. The effect of mutations in these two genes in resected NSCLC remains controversial.Methods: We searched Internet databases for studies reporting disease-free survival (DFS) and overall survival (OS) in resected NSCLC patients with EGFR or KRAS mutations. A meta-analysis cal...
Recent studies have reported that clinical response to epidermal growth factor receptor (EGFR) inhib...
BACKGROUND/AIM: Gefitinib and erlotinib were shown to be particularly effective in a clinically sele...
Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSC...
The prognostic value of epidermal growth factor receptor (EGFR) mutations in resected non-small cell...
IntroductionThe prognostic role of epidermal growth factor receptor (EGFR) mutations in patients wit...
<div><p>Background</p><p>The prognostic value of epidermal growth factor receptor (EGFR) mutations i...
<div><p>Clinical implications of KRAS mutations in advanced non-small cell lung cancer remain unclea...
OBJECTIVES: Surgery yields best results for non-small cell lung cancer (NSCLC) patients. Epidermal g...
IntroductionThe prognostic role of epidermal growth factor receptor (EGFR) mutations in patients wit...
[[abstract]]INTRODUCTION:: The prognostic role of epidermal growth factor receptor (EGFR) mutations ...
BackgroundSomatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in lung adenocarci...
[[abstract]]INTRODUCTION:: The prognostic role of epidermal growth factor receptor (EGFR) mutations ...
BackgroundSomatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in lung adenocarci...
Background and objective Epidermal growth factor receptor (EGFR) and KRAS status were particularly c...
Introduction:Although mutation of the epidermal growth factor receptor (EGFR) gene is predictive for...
Recent studies have reported that clinical response to epidermal growth factor receptor (EGFR) inhib...
BACKGROUND/AIM: Gefitinib and erlotinib were shown to be particularly effective in a clinically sele...
Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSC...
The prognostic value of epidermal growth factor receptor (EGFR) mutations in resected non-small cell...
IntroductionThe prognostic role of epidermal growth factor receptor (EGFR) mutations in patients wit...
<div><p>Background</p><p>The prognostic value of epidermal growth factor receptor (EGFR) mutations i...
<div><p>Clinical implications of KRAS mutations in advanced non-small cell lung cancer remain unclea...
OBJECTIVES: Surgery yields best results for non-small cell lung cancer (NSCLC) patients. Epidermal g...
IntroductionThe prognostic role of epidermal growth factor receptor (EGFR) mutations in patients wit...
[[abstract]]INTRODUCTION:: The prognostic role of epidermal growth factor receptor (EGFR) mutations ...
BackgroundSomatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in lung adenocarci...
[[abstract]]INTRODUCTION:: The prognostic role of epidermal growth factor receptor (EGFR) mutations ...
BackgroundSomatic mutations in EGFR (exons 19 and 21) and KRAS (exon 2) are found in lung adenocarci...
Background and objective Epidermal growth factor receptor (EGFR) and KRAS status were particularly c...
Introduction:Although mutation of the epidermal growth factor receptor (EGFR) gene is predictive for...
Recent studies have reported that clinical response to epidermal growth factor receptor (EGFR) inhib...
BACKGROUND/AIM: Gefitinib and erlotinib were shown to be particularly effective in a clinically sele...
Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSC...